Dr. Wolfgang Knirsch – CEO of Vita 34 AG
Dr. Wolfgang Knirsch, born in 1960, has been a member of the board of Vita 34 AG since June 2016 and was appointed CEO of Vita 34 AG in June 2017.
After he received his PhD in inorganic chemistry by RWTH Aachen, Dr. Wolfgang Knirsch made a shift from institutional research to the pharmaceutical industry in 1992.
He started his career in the sales and marketing division of Hoechst AG. Later, he was in charge of the product management of internationally relevant ethical preparations of the successor company Aventis Pharma GmbH. When he went to work for Merck KGaA, he became responsible for new business and national marketing of the company’s most important product sector.
In 2005, Dr. Knirsch took over the management of the operational and strategic marketing of Biotest AG. After the successful restructuring and reorganization of the division, he made a shift to the international line of business in 2011. In his position as Vice President of International Business, he successfully advanced the strategically relevant department worth several hundred millions of Euros involving distribution partners worldwide.
Andreas Schafhirt – CFO of Vita 34 AG
Andreas Schafhirt, born in 1962, was appointed CFO of Vita 34 in August 2021.
He studied economics and Industrial Engineering at the Technical University of Berlin and graduated with a degree in economics. Subsequently, Mr Schafhirt started at Berliner Industriebank AG, where he was involved, among other things, with the implementation of credit programmes for the promotion of the economy in eastern Germany. He then moved to the stationery industry and took over the management and further development of the accounting, controlling and finance department at Herlitz AG. In 2000, he became CFO of the Protective & Decorative Finishes Division at packaging manufacturer Impress B.V., based in Amsterdam and Paris, where he was in charge of the post-merger integration of two parts of the company. His career then took him back to the office supplies industry as CFO of Biella-Neher AG in Switzerland. Milestones were the IPO in 2006, numerous M&A transactions and restructurings as well as the sale of the company in a structured bidding process with subsequent integration.